surmount-1 tirzepatide trial weight loss non-diabetic after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 GLP-1-based combination strategies for weight

In some cases, people have serious side effects because they have a health problem that increases their risk

[1] NICE guidance (NG28) recommends GLP-1 receptor agonists like semaglutide for adults with type 2 diabetes when: Triple therapy with metformin and two other oral drugs is ineffective, not tolerated, or contraindicated The person has a BMI of 35 kg/m or higher (adjusted for ethnicity) and specific psychological or medical problems associated with obesity BMI is lower than 35 kg/m but insulin therapy would have significant occupational implications or weight loss would benefit other obesity-related comorbidities Ozempic is available in pre-filled, multi-dose pens delivering 0.25 mg, 0.5 mg, 1 mg, or 2 mg doses

Sheng Y, Wu T, Dai Y, Xu L, Zhong Y, Xue Y, Tian Y (2020a) 6-gingerol alleviates inflammatory injury in DSS-induced ulcerative colitis mice by regulating NF-B signaling

If you follow a vegan or vegetarian diet, consider taking supplements or consuming fortified foods

Magnesium: the forgotten electrolytea review on hypomagnesemia